CYGB and cancer: We first assessed CYGB expression in non-tumor and tumor areas of human (h)PDAC tissue exhibiting malignant ductal proliferation surrounded by dense ECM, αSMA-positive myofibroblasts, and cancer cells positive for the DNA damage markers P53 and 53BP1 (Supplemental Fig. 1A).